These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage. Visser N; Herreman LCM; Vandooren J; Pereira RVS; Opdenakker G; Spelbrink REJ; Wilbrink MH; Bremer E; Gosens R; Nawijn MC; van der Ende-Metselaar HH; Smit JM; Laus MC; Laman JD J Mol Med (Berl); 2024 Apr; 102(4):521-536. PubMed ID: 38381158 [TBL] [Abstract][Full Text] [Related]
28. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19. Sinha S; Sehgal A; Sehgal R Drug Discov Ther; 2020; 14(4):161-170. PubMed ID: 32908071 [TBL] [Abstract][Full Text] [Related]
29. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV. Lubbe L; Cozier GE; Oosthuizen D; Acharya KR; Sturrock ED Clin Sci (Lond); 2020 Nov; 134(21):2851-2871. PubMed ID: 33146371 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics. Singh SP; Bhatnagar A; Singh SK; Patra SK; Kanwar N; Kanwal A; Amar S; Manna R Mini Rev Med Chem; 2022; 22(16):2102-2123. PubMed ID: 35105287 [TBL] [Abstract][Full Text] [Related]
31. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? Nicolau LAD; Magalhães PJC; Vale ML Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925 [TBL] [Abstract][Full Text] [Related]
32. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice. Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370 [TBL] [Abstract][Full Text] [Related]
33. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication. Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378 [TBL] [Abstract][Full Text] [Related]
34. The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection. Schieffer E; Schieffer B J Renin Angiotensin Aldosterone Syst; 2022; 2022():2549063. PubMed ID: 35685188 [TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection. Vitiello A; Ferrara F Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743089 [TBL] [Abstract][Full Text] [Related]
36. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic. Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238 [TBL] [Abstract][Full Text] [Related]
37. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
38. COVID-19 and L-arginine Supplementations: Yet to Find the Missed Key. Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Batiha GE Curr Protein Pept Sci; 2022; 23(3):166-169. PubMed ID: 35549865 [TBL] [Abstract][Full Text] [Related]
39. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications. Banu N; Panikar SS; Leal LR; Leal AR Life Sci; 2020 Sep; 256():117905. PubMed ID: 32504757 [TBL] [Abstract][Full Text] [Related]
40. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection. Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]